Treatment of severe spacticity in multiple sclerosis by continuous intrathecal baclofen
Background. Successful treatment of severe spasticity represents an imperative of symptomatic therapy of multiple sclerosis (MS) due to a significant improvement of physical, psychic and social rehabilitation of MS patients, as well as a longterm cost savings for the additional treatments of conditi...
Saved in:
| Main Authors: | Perić Predrag, Antić Branislav, Dinčić Evica, Obradović Dragana, Arsić Stojanka |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade
2006-01-01
|
| Series: | Vojnosanitetski Pregled |
| Subjects: | |
| Online Access: | http://www.doiserbia.nb.rs/img/doi/0042-8450/2006/0042-84500602187P.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and Immunological Impact of Intrathecal Baclofen Pumps in Managing Spasticity in Multiple Sclerosis in Adult Patients: A Systematic Review
by: Billy McBenedict, et al.
Published: (2025-01-01) -
Intrathecal baclofen therapy in patients with spastic paraplegia: retrospective evaluation of pretreatment drugs, test dosage, dose increments and final therapy
by: Stephan Kurz, et al.
Published: (2025-01-01) -
Continuous intrathecal baclofen delivery in severely disabling spasticity
by: Simsek Hakan, et al.
Published: (2018-01-01) -
A Study to Compare Efficacy of Oral Baclofen versus Oral Tizanidine in Post-stroke Spasticity of Upper Limb
by: Ankita Singha Roy, et al.
Published: (2025-05-01) -
A complicated intrathecal baclofen pump implantation in a child with spastic Diplegia: Should a genetic mimic of cerebral palsy be Considered?
by: Mohamed Ashraf, et al.
Published: (2025-09-01)